Skip to main content
. Author manuscript; available in PMC: 2013 Sep 11.
Published in final edited form as: J Clin Pharmacol. 2010 Apr 23;51(3):309–320. doi: 10.1177/0091270010368542

Table III.

Pre- and Posttransplant IMPDH Activity Parameters Obtained, Expressed as nmol/h/mg Protein

Pretransplant (Baseline Before Dosing)
Early Posttransplant (1–3 Days)
Prior to Discharge (5–9 Days)
Stable Period (Approximately 6 Months)
(n = 19) (n = 21) (n = 19) (n = 13)
Range
Range
Range
Range
Mean Min Max SD Mean Min Max SD Mean Min Max SD Mean Min Max SD
Age at transplant, y 12.4 2.1 20.2 5.3 13.5 4.1 20.2 4.5 13.6 4.1 20.2 4.5 15.1 10.6 18.7 2.1
Age group: ≥2 and <6/≥6 and <12/≥12 to 18 years 4:2:13 3:1:17 3:0:16 0:1:12
Predose IMPDH activity, nmol/h/mg protein 6.4 1.0 18.4 4.6 4.1 0.3 13.1 2.8 3.1 0.8 7.0 1.6 1.7 0.1 3.4 1.1
Nadir IMPDH activity, nmol/h/mg proteina 1.9 0.1 5.4 1.7 1.1 0.1 3.1 0.8 0.5 0.1 1.3 0.4
% Inhibition/ predose 53 0 82 28 65 19 91 18 62 0 90 27
(n = 13) (n = 12) (n = 9)
% Inhibition/ baseline 65 –34 93 40 84 64 97 11 87 46 99 17

Parameter values are reported as means with standard deviations (SD) and ranges. IMPDH, inosine monophosphate dehydrogenase.

a

Minimum IMPDH activity is defined as the lowest IMPDH activity observed after administration of a dose of mycophenolate mofetil.